Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease

被引：0
|
作者：
Milosevic, V. [1 ]
Petrovic, M. [1 ]
Mihaljevic, B. [1 ]
Jankovic, S. [1 ]
Nedeljkov, R. Jancic [1 ]
Boskovic, D. [1 ]
机构：
[1] Inst Hematol, Belgrade, Serbia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1239
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [31] Gemcitabine, Vinorelbine and Pegylated Liposomal Doxorubicin (GVD) in the Treatment of Relapsed or Refractory Hodgkin's Lymphoma - Experience of a Portuguese Center
    Queiroz, Luisa Vilaca
    Fidalgo, Paula
    Moreira, Claudia
    Ilda, Faustino
    Pantarotto, Marcos
    Ferreira, Marta
    Lombo, Liliana
    Pereira, Dulcineia
    Pina, Idilia
    Mariano, Monica
    Rodrigues, Angelo
    Santo, Ana Espirito
    Martins, Angelo
    Moreira, Ilidia
    Oliveira, Isabel
    Marques, Margarida
    Viterbo, Luisa
    Domingues, Nelson
    Mariz, Jose Mario
    BLOOD, 2012, 120 (21)
  • [32] Gemcitabine as single agent in the treatment of relapsed or refractory aggressive non-Hodgkin lymphoma (NHL)
    Welt, A
    Fossa, A
    Blatter, J
    Buksmaui, S
    Seeber, S
    Nowrousian, MR
    ANNALS OF ONCOLOGY, 1998, 9 : 168 - 168
  • [33] A multicenter study of a gemcitabine-based regimen in relapsed or refractory Hodgkin's lymphoma patients
    Validire, Patricia
    Ferme, Christophe
    Brice, Pauline
    Divine, Marine
    Gabarre, Jean
    Bouabdallah, Krimo
    Fitoussi, Olivier
    Chaoui, Driss
    Pacquement, Helene
    Soussain, Carole
    Carde, Patrice
    Sahli, Rafika
    Decaudin, Didier
    BLOOD, 2007, 110 (11) : 178B - 178B
  • [34] Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma
    Ozdemir, Evren
    Aslan, Alma
    Turker, Alev
    Barista, Ibrahim
    Kars, Ayse
    BLOOD, 2015, 126 (23)
  • [35] A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
    Cohen, Jonathon B.
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
  • [36] A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients
    Validire, Patricia
    Ferme, Christophe
    Brice, Pauline
    Divine, Marine
    Gabarre, Jean
    Bouabdallah, Krimo
    Fitoussi, Olivier
    Chaoui, Driss
    Pacquement, Helene
    Soussain, Carole
    Carde, Patrice
    Salhi, Rafika
    Zanni, Manuela
    Decaudin, Didier
    ANTI-CANCER DRUGS, 2008, 19 (03) : 309 - 315
  • [37] A multicenter study of a gemcitabine-based regimen in relapsed or refractory Hodgkin's lymphoma patients
    Validire, P.
    Ferme, C.
    Brice, P.
    Divine, M.
    Gabarre, J.
    Bouabdallah, K.
    Fitoussi, O.
    Chaoui, D.
    Pacquement, H.
    Soussain, C.
    Garde, P.
    Salhi, R.
    Decaudin, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 78 - 78
  • [38] Nonmyeloablative stem cell transplantation in refractory or relapsed Hodgkin's disease
    Seyfarth, B
    Bornhäuser, M
    Fernández-Avilés, F
    Caballero, M
    Hernández-Navarro, F
    Hegenbart, K
    Arranz, R
    Basara, N
    Diez, J
    Kobbe, G
    Sanz, G
    Schwerdtfeger, R
    Martino, R
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 2002, 29 : S150 - S150
  • [39] Treatment of Relapsing/Refractory Hodgkin's Disease
    Gorenkova, Liliya
    Kravchenko, Sergey K.
    Klebanova, Elizaveta
    Moiseeva, Tatiyana
    Mangasarova, Yana K.
    Magomedova, Aminat U.
    Savchenko, Valery G.
    BLOOD, 2018, 132
  • [40] Gemncitabine as a single agent in the treatment of relapsed or refractory Hodgkin's and non Hodgkin's lymphoma.
    Jajeh, A
    Hadad, L
    Zalzaleh, G
    Abboud, W
    Nukala, S
    BLOOD, 2002, 100 (11) : 299B - 299B
12345